Clinical trialNCT07599982RecruitingInterventional

Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With Diabetes

SponsorDreaMed DiabetesEnrollment102Type 1 Diabetes (T1D)Type 2 Diabetes (T2D)

View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

A 13-week multi-center single-arm trial, preceded by a 2-week standard therapy phase, will be conducted to assess the safety of MODI, an insulin titration algorithm, in adults with type 1 diabetes (T1D) who use multiple daily insulin injections (MDI), or with type 2 diabetes (T2D) who use MDI, basal insulin only, or who are candidates to initiate basal insulin, in conjunction with continuous glucose monitoring (CGM).

clinicaltrials.gov ↗

Investigators

No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

Henry Ford Health System
Detroit, Michigan, United States
Davida Kruger
Recruiting
Suny Upstate Medical Center
Albany, New York, United States
Malek El Muayed, MD
Recruiting
Texas Diabetes & Endocrinology
Austin, Texas, United States
Thomas Blevins, MD
Recruiting
Diabetes & Endocrine Treatment Specialisits (dets)
Sandy City, Utah, United States
Timothy Graham, MD
Recruiting

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 25 May 2026
Primary completion: 31 Jan 2027
Completion: 31 Jan 2027
Last update posted: 22 Jul 2026
Registered enrollment: 102
Registry id: NCT07599982

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.